Literature DB >> 8004584

Leukemic meningitis in a patient with splenic lymphoma with villous lymphocytes (SLVL). Meningitis as a possible initial manifestation of SLVL.

K Yamazaki1, S Shimizu, T Negami, K Sawada, H Nanasawa, M Ohta, S Konda, K Okuda.   

Abstract

BACKGROUND: Splenic lymphoma with villous lymphocytes (SLVL) is a low grade, non-Hodgkin's lymphoma with a stable or slowly progressive clinical course. To the authors' knowledge, central nervous system involvement has not been described previously in patients with SLVL.
METHODS: Morphologic, immunocytochemical, and immunohistochemical analyses were conducted to determine the nature of villous lymphocytes in the peripheral blood, spleen, and cerebrospinal fluid (CSF) of a patient with massive splenomegaly.
RESULTS: A diagnosis of SLVL was made, based on tartrate-resistant acid phosphatase-negative peripheral villous lymphocytosis with CD19+, CD20+, HLA-DR+ phenotypes, and the involvement of spleen white pulp with these cells. Mononuclear cells in the CSF showed the same morphologic and immunocytochemical features seen in the villous lymphocytes in the peripheral blood and spleen. Splenectomy and intrathecal chemotherapy were successful in clearing leukemic cells from the CSF.
CONCLUSION: In this patient with SLVL in whom leukemic meningitis developed, meningitis was found to be a possible initial manifestation of SLVL.

Entities:  

Mesh:

Year:  1994        PMID: 8004584     DOI: 10.1002/1097-0142(19940701)74:1<61::aid-cncr2820740111>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Meningeal lymphomatosis as the first manifestation of splenic marginal zone lymphoma.

Authors:  Jordi Bruna; Sergio Martínez-Yelamos; Esther Alonso; Vicente Romagosa; Jordi Arruga; Jordi Arruga; Alicia Domingo; Iñigo Rojas-Marcos; Josep Petit; Francisco Rubio
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

2.  A patient with splenic marginal zone lymphoma presenting with spastic paraplegia as the initial symptom.

Authors:  Yuko Wada; Yo Nishimura; Kimio Hashimoto
Journal:  Case Rep Neurol       Date:  2011-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.